Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed non-small cell lung cancer (NSCLC)
Achieved resectability after neoadjuvant immunotherapy with or without chemotherapy
Initially required pneumonectomy or combined lobectomy based on tumor size and extent, but became suitable for minimally invasive resection after neoadjuvant treatment
Age ≥ 18 years
ECOG performance status score of 0-1
Complete imaging, pathological, and follow-up data available
You may not be if
Disease progression (PD) after neoadjuvant therapy
Still required pneumonectomy or combined lobectomy after neoadjuvant therapy, with no reduction in the planned surgical extent
Intraoperative findings indicating that R0 resection was not feasible
Severe cardiopulmonary dysfunction or other complications that made the patient unable to tolerate surgery
Clareo Health | Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
